Herpes Labialis Treatment Market 2027 By Drug Class, Route of Administration, Distribution Channel | The Insight Partners

Herpes Labialis Treatment Market to 2027 - Global Analysis and Forecasts by Drug Class (Acyclovir, Valacyclovir, Penciclovir, Famciclovir, Docosanol); Route of Administration (Oral, Topical, Combination); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies)

Report Code: TIPRE00005927 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION

Herpes Labialis, commonly referred to as cold sore is a typical type of infection caused through the herpes simplex virus that primarily affects the lip. Symptoms for herpes labialis include burning pain followed by blisters or sores or the first attack may be followed by fever, sore throat and enlarged lymph nodes.

MARKET DYNAMICS

The Herpes Labialis Treatment market is anticipated to grow in the forecast, owing to the factors such as rising prevalence of viral infections, rise in research and development investments, mergers and acquisitions by the leading market players, and growing efforts and investments in examining clinical efficacy of drugs.

MARKET SCOPE

The "Global Herpes Labialis Treatment Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Herpes Labialis Treatment market with detailed market segmentation by drug class, route of administration, distribution channel and geography. The global Herpes Labialis Treatment market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Herpes Labialis Treatment market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global Herpes Labialis Treatment market is segmented on the basis of drug class, route of administration and distribution channel. Based on drug class the market is segmented into Acyclovir, Valacyclovir, Penciclovir, Famciclovir, Docosanol, Others. Based on route of administration the market is segmented into Oral, Topical, Combination. Based on distribution channel the market is segmented into Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies.


REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Herpes Labialis Treatment market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Herpes Labialis Treatment market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Herpes Labialis Treatment market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Herpes Labialis Treatment market in these regions.


MARKET PLAYERS

The reports cover key developments in the Herpes Labialis Treatment market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Herpes Labialis Treatment market are anticipated to lucrative growth opportunities in the future with the rising demand for Herpes Labialis Treatment market in the global market. Below mentioned is the list of few companies engaged in the Herpes Labialis Treatment market.

The report also includes the profiles of Herpes Labialis Treatment market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

- Bausch Health (Valeant Pharmaceuticals)
- Asahi Kasei Corporation.
- Onxeo
- VECTANS PHARMA
- ALLERGAN
- Abbott
- Sun Pharmaceutical Industries Ltd
- Pfizer Inc
- Mylan N.V
- GlaxoSmithKline plc

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Herpes Labialis Treatment Market - By Drug Class
1.3.2 Herpes Labialis Treatment Market - By Route of Administration
1.3.3 Herpes Labialis Treatment Market - By Distribution Channel
1.3.4 Herpes Labialis Treatment Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. HERPES LABIALIS TREATMENT MARKET L and SCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. HERPES LABIALIS TREATMENT MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS and RESTRAINTS
6. HERPES LABIALIS TREATMENT MARKET - GLOBAL MARKET ANALYSIS
6.1. HERPES LABIALIS TREATMENT - GLOBAL MARKET OVERVIEW
6.2. HERPES LABIALIS TREATMENT - GLOBAL MARKET and FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. HERPES LABIALIS TREATMENT MARKET - REVENUE and FORECASTS TO 2027 - DRUG CLASS
7.1. OVERVIEW
7.2. DRUG CLASS MARKET FORECASTS and ANALYSIS
7.3. ACYCLOVIR
7.3.1. Overview
7.3.2. Acyclovir Market Forecast and Analysis
7.4. VALACYCLOVIR
7.4.1. Overview
7.4.2. Valacyclovir Market Forecast and Analysis
7.5. PENCICLOVIR
7.5.1. Overview
7.5.2. Penciclovir Market Forecast and Analysis
7.6. FAMCICLOVIR
7.6.1. Overview
7.6.2. Famciclovir Market Forecast and Analysis
7.7. DOCOSANOL
7.7.1. Overview
7.7.2. Docosanol Market Forecast and Analysis
8. HERPES LABIALIS TREATMENT MARKET - REVENUE and FORECASTS TO 2027 - ROUTE OF ADMINISTRATION
8.1. OVERVIEW
8.2. ROUTE OF ADMINISTRATION MARKET FORECASTS and ANALYSIS
8.3. ORAL
8.3.1. Overview
8.3.2. Oral Market Forecast and Analysis
8.4. TOPICAL
8.4.1. Overview
8.4.2. Topical Market Forecast and Analysis
8.5. COMBINATION
8.5.1. Overview
8.5.2. Combination Market Forecast and Analysis
9. HERPES LABIALIS TREATMENT MARKET - REVENUE and FORECASTS TO 2027 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS and ANALYSIS
9.3. HOSPITAL PHARMACIES
9.3.1. Overview
9.3.2. Hospital Pharmacies Market Forecast and Analysis
9.4. RETAIL PHARMACIES
9.4.1. Overview
9.4.2. Retail Pharmacies Market Forecast and Analysis
9.5. DRUG STORES
9.5.1. Overview
9.5.2. Drug Stores Market Forecast and Analysis
9.6. ONLINE PHARMACIES
9.6.1. Overview
9.6.2. Online Pharmacies Market Forecast and Analysis
10. HERPES LABIALIS TREATMENT MARKET REVENUE and FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Herpes Labialis Treatment Market Overview
10.1.2 North America Herpes Labialis Treatment Market Forecasts and Analysis
10.1.3 North America Herpes Labialis Treatment Market Forecasts and Analysis - By Drug Class
10.1.4 North America Herpes Labialis Treatment Market Forecasts and Analysis - By Route of Administration
10.1.5 North America Herpes Labialis Treatment Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Herpes Labialis Treatment Market Forecasts and Analysis - By Countries
10.1.6.1 United States Herpes Labialis Treatment Market
10.1.6.1.1 United States Herpes Labialis Treatment Market by Drug Class
10.1.6.1.2 United States Herpes Labialis Treatment Market by Route of Administration
10.1.6.1.3 United States Herpes Labialis Treatment Market by Distribution Channel
10.1.6.2 Canada Herpes Labialis Treatment Market
10.1.6.2.1 Canada Herpes Labialis Treatment Market by Drug Class
10.1.6.2.2 Canada Herpes Labialis Treatment Market by Route of Administration
10.1.6.2.3 Canada Herpes Labialis Treatment Market by Distribution Channel
10.1.6.3 Mexico Herpes Labialis Treatment Market
10.1.6.3.1 Mexico Herpes Labialis Treatment Market by Drug Class
10.1.6.3.2 Mexico Herpes Labialis Treatment Market by Route of Administration
10.1.6.3.3 Mexico Herpes Labialis Treatment Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Herpes Labialis Treatment Market Overview
10.2.2 Europe Herpes Labialis Treatment Market Forecasts and Analysis
10.2.3 Europe Herpes Labialis Treatment Market Forecasts and Analysis - By Drug Class
10.2.4 Europe Herpes Labialis Treatment Market Forecasts and Analysis - By Route of Administration
10.2.5 Europe Herpes Labialis Treatment Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Herpes Labialis Treatment Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Herpes Labialis Treatment Market
10.2.6.1.1 Germany Herpes Labialis Treatment Market by Drug Class
10.2.6.1.2 Germany Herpes Labialis Treatment Market by Route of Administration
10.2.6.1.3 Germany Herpes Labialis Treatment Market by Distribution Channel
10.2.6.2 France Herpes Labialis Treatment Market
10.2.6.2.1 France Herpes Labialis Treatment Market by Drug Class
10.2.6.2.2 France Herpes Labialis Treatment Market by Route of Administration
10.2.6.2.3 France Herpes Labialis Treatment Market by Distribution Channel
10.2.6.3 Italy Herpes Labialis Treatment Market
10.2.6.3.1 Italy Herpes Labialis Treatment Market by Drug Class
10.2.6.3.2 Italy Herpes Labialis Treatment Market by Route of Administration
10.2.6.3.3 Italy Herpes Labialis Treatment Market by Distribution Channel
10.2.6.4 Spain Herpes Labialis Treatment Market
10.2.6.4.1 Spain Herpes Labialis Treatment Market by Drug Class
10.2.6.4.2 Spain Herpes Labialis Treatment Market by Route of Administration
10.2.6.4.3 Spain Herpes Labialis Treatment Market by Distribution Channel
10.2.6.5 United Kingdom Herpes Labialis Treatment Market
10.2.6.5.1 United Kingdom Herpes Labialis Treatment Market by Drug Class
10.2.6.5.2 United Kingdom Herpes Labialis Treatment Market by Route of Administration
10.2.6.5.3 United Kingdom Herpes Labialis Treatment Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Herpes Labialis Treatment Market Overview
10.3.2 Asia-Pacific Herpes Labialis Treatment Market Forecasts and Analysis
10.3.3 Asia-Pacific Herpes Labialis Treatment Market Forecasts and Analysis - By Drug Class
10.3.4 Asia-Pacific Herpes Labialis Treatment Market Forecasts and Analysis - By Route of Administration
10.3.5 Asia-Pacific Herpes Labialis Treatment Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Herpes Labialis Treatment Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Herpes Labialis Treatment Market
10.3.6.1.1 Australia Herpes Labialis Treatment Market by Drug Class
10.3.6.1.2 Australia Herpes Labialis Treatment Market by Route of Administration
10.3.6.1.3 Australia Herpes Labialis Treatment Market by Distribution Channel
10.3.6.2 China Herpes Labialis Treatment Market
10.3.6.2.1 China Herpes Labialis Treatment Market by Drug Class
10.3.6.2.2 China Herpes Labialis Treatment Market by Route of Administration
10.3.6.2.3 China Herpes Labialis Treatment Market by Distribution Channel
10.3.6.3 India Herpes Labialis Treatment Market
10.3.6.3.1 India Herpes Labialis Treatment Market by Drug Class
10.3.6.3.2 India Herpes Labialis Treatment Market by Route of Administration
10.3.6.3.3 India Herpes Labialis Treatment Market by Distribution Channel
10.3.6.4 Japan Herpes Labialis Treatment Market
10.3.6.4.1 Japan Herpes Labialis Treatment Market by Drug Class
10.3.6.4.2 Japan Herpes Labialis Treatment Market by Route of Administration
10.3.6.4.3 Japan Herpes Labialis Treatment Market by Distribution Channel
10.3.6.5 South Korea Herpes Labialis Treatment Market
10.3.6.5.1 South Korea Herpes Labialis Treatment Market by Drug Class
10.3.6.5.2 South Korea Herpes Labialis Treatment Market by Route of Administration
10.3.6.5.3 South Korea Herpes Labialis Treatment Market by Distribution Channel
10.4. MIDDLE EAST and AFRICA
10.4.1 Middle East and Africa Herpes Labialis Treatment Market Overview
10.4.2 Middle East and Africa Herpes Labialis Treatment Market Forecasts and Analysis
10.4.3 Middle East and Africa Herpes Labialis Treatment Market Forecasts and Analysis - By Drug Class
10.4.4 Middle East and Africa Herpes Labialis Treatment Market Forecasts and Analysis - By Route of Administration
10.4.5 Middle East and Africa Herpes Labialis Treatment Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Herpes Labialis Treatment Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Herpes Labialis Treatment Market
10.4.6.1.1 South Africa Herpes Labialis Treatment Market by Drug Class
10.4.6.1.2 South Africa Herpes Labialis Treatment Market by Route of Administration
10.4.6.1.3 South Africa Herpes Labialis Treatment Market by Distribution Channel
10.4.6.2 Saudi Arabia Herpes Labialis Treatment Market
10.4.6.2.1 Saudi Arabia Herpes Labialis Treatment Market by Drug Class
10.4.6.2.2 Saudi Arabia Herpes Labialis Treatment Market by Route of Administration
10.4.6.2.3 Saudi Arabia Herpes Labialis Treatment Market by Distribution Channel
10.4.6.3 U.A.E Herpes Labialis Treatment Market
10.4.6.3.1 U.A.E Herpes Labialis Treatment Market by Drug Class
10.4.6.3.2 U.A.E Herpes Labialis Treatment Market by Route of Administration
10.4.6.3.3 U.A.E Herpes Labialis Treatment Market by Distribution Channel
10.5. SOUTH and CENTRAL AMERICA
10.5.1 South and Central America Herpes Labialis Treatment Market Overview
10.5.2 South and Central America Herpes Labialis Treatment Market Forecasts and Analysis
10.5.3 South and Central America Herpes Labialis Treatment Market Forecasts and Analysis - By Drug Class
10.5.4 South and Central America Herpes Labialis Treatment Market Forecasts and Analysis - By Route of Administration
10.5.5 South and Central America Herpes Labialis Treatment Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Herpes Labialis Treatment Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Herpes Labialis Treatment Market
10.5.6.1.1 Brazil Herpes Labialis Treatment Market by Drug Class
10.5.6.1.2 Brazil Herpes Labialis Treatment Market by Route of Administration
10.5.6.1.3 Brazil Herpes Labialis Treatment Market by Distribution Channel
10.5.6.2 Argentina Herpes Labialis Treatment Market
10.5.6.2.1 Argentina Herpes Labialis Treatment Market by Drug Class
10.5.6.2.2 Argentina Herpes Labialis Treatment Market by Route of Administration
10.5.6.2.3 Argentina Herpes Labialis Treatment Market by Distribution Channel
11. INDUSTRY L and SCAPE
11.1. MERGERS and ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS and JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS and OTHER STRATEGIC DEVELOPMENTS
12. HERPES LABIALIS TREATMENT MARKET, KEY COMPANY PROFILES
12.1. BAUSCH HEALTH (VALEANT PHARMACEUTICALS)
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. ASAHI KASEI CORPORATION
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. ONXEO
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. VECTANS PHARMA
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. ALLERGAN
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. ABBOTT
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. SUN PHARMACEUTICAL INDUSTRIES LTD
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. PFIZER INC
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. MYLAN N.V
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. GLAXOSMITHKLINE PLC
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

- Bausch Health (Valeant Pharmaceuticals)
- Asahi Kasei Corporation.
- Onxeo
- VECTANS PHARMA
- ALLERGAN
- Abbott
- Sun Pharmaceutical Industries Ltd
- Pfizer Inc
- Mylan N. V
- GlaxoSmithKline plc